Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Japan

Japan Articles

Industry

With the aim of expanding its presence in the world's second-largest drug market, German drugmaker Boehringer Ingelheim is to acquire the remaining stake in SSP, its subsidiary company... 2010-02-11


Industry

Two patented drugs for the treatment of diabetes - Novo Nordisk's Victoza (liraglutide) and Novartis's Equa (vildagliptin) - have been registered in Japan. Despite the current popularity... 2010-01-21


Industry

Japan is the most attractive market for multinational drugmakers operating in Asia Pacific, according to BMI's recently compiled Q210 Pharmaceuticals & Healthcare Business Environment... 2010-01-11


More ARTICLES

Industry

BMI's Drug Expenditure Forecast Model reveals that medicine sales in Asia Pacific will more than double over the next decade. Key drivers of growth are expanding economies, rising... 2009-12-21


Industry

BMI is maintaining its short- and long-term forecasts for Japan's pharmaceutical market, despite the announcement of a possible 6.2% price cut to prescription drugs next year. This... 2009-12-04


Industry

One of BMI's core views for the pharmaceuticals and healthcare industry is that emerging markets will drive global medicine sales. However, not all drugmakers subscribe to this opinion.... 2009-09-17


Industry

The US leads BMI's global Pharmaceuticals & Healthcare Business Environment Ratings with a score of 72.4 out of 100. It is the world's largest market for medicines, with a well-established... 2009-09-09


Industry

Pharmaceutical sales in Japan are forecast to grow by a modest 1.95% in local currency terms during 2009. This rate of expansion is below the 2004-08 compound annual growth rate (CAGR)... 2009-08-13